Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Inflexion is a leading European mid-market private equity firm with a significant and active investment focus on the healthcare and life sciences sectors. The firm specializes in buyouts and growth capital, frequently partnering with management teams to drive international expansion and operational improvements. Inflexion's healthcare portfolio includes major global players such as Inizio (a healthcare communications and commercialization platform), Pharmathen (a drug delivery technology company), and Curium (a world leader in nuclear medicine). For a biotech analyst, Inflexion is a critical entity to monitor due to its role as a major consolidator of pharmaceutical services and its active participation in the M&A landscape for mid-sized healthcare companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Inflexion Partners.